Join us as we delve into innovative solutions transforming methadone dispensing at opioid treatment provider clinics. This episode unpacks revolutionary capabilities that enhance communication and treatment for clinicians and patients. Learn how Opio is redefining interactions with opioid providers and their systems, spotlighting early collaborations, and sharing initial successes. Discover how their creative models are improving information exchange between providers, patients, and payers, and explore strategic partnerships and growth plans.

What You'll Learn About

• How a robotic solution is innovating methadone dispensing in opioid treatment clinics.
• The unique capabilities that improve communication between clinicians and patients.
• Details of interoperability with major healthcare systems to enhance information exchange.
• Strategies for ensuring HIPAA-compliant infrastructure in opioid care settings.
• Insights into partnerships and growth plans within the healthcare technology space.

MODERATOR:Taylor McPartland CEO, ScaleHealth

Taylor, a native of Northern California, began his entrepreneurial journey by co-founding his first company in 2010, where he served as a leader for the following 6 years. Throughout this period, he developed a profound passion for harnessing innovation to tackle the systemic challenges our society faces on a daily basis. Motivated by this mission, Taylor established ScaleHealth in 2018 with a vision to create a global health innovation ecosystem that ensures universal access to cutting-edge healthcare solutions, promoting overall well-being. Since its inception, ScaleHealth has played a pivotal role in scaling startups worldwide while enabling health systems and partners to save time and money while accelerating impact and outcomes.

GUEST: Sam Wilson Chief Operating Officer, Opio

Sam has spent her career tackling big problems in behavioral healthcare. As the COO of Opio, she's working to support Opioid Treatment Programs (OTPs) through robotic automations and software solutions. Previously, she co-founded Confidant Health, a multi-state behavioral health tech platform focused on value-based care and led the development of ATLAS, the nation’s first quality rating system for addiction treatment programs while working at Shatterproof, a national nonprofit dedicated to reversing the addiction crisis. Sam also worked on state and federal policy to expand access to evidence-based addiction treatments at the Pew Charitable Trusts in Washington DC. She also advises several startups in the behavioral and women’s health spaces, and works as a doula in her community. She is a mom and avid adventure seeker.

The CHIME Opioid Task Force (OTF) was launched in early 2018 with a simple mission: to turn the tide on the opioid epidemic using the knowledge and expertise of the nation’s healthcare IT leaders. While our mission is simple, achieving it is not. Opioid addictin is a complex disease that requires long-term, if not lifetime, care from well-informed clinicians who are supported with easy-to-use and reliable tools.